HEADER TRANSFERASE 29-OCT-03 1URF TITLE HR1B DOMAIN FROM PRK1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KINASE C-LIKE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: HR1B, RESIDUES 122-199; COMPND 5 SYNONYM: PLK1_HUMAN, PROTEIN-KINASE C-RELATED KINASE 1, PROTEIN COMPND 6 KINASE C-LIKE PKN, SERINE-THREONINE PROTEIN KINASE N; COMPND 7 EC: 2.7.1.-; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PGEX-3X KEYWDS TRANSFERASE, G-PROTEIN, HR1 DOMAIN, KINASE, HELICAL, COILED COIL, KEYWDS 2 ATP-BINDING, SERINE/THREONINE-PROTEIN KINASE, PHOSPHORYLATION EXPDTA SOLUTION NMR NUMMDL 24 AUTHOR D.OWEN,P.N.LOWE,D.NIETLISPACH,C.E.BROSNAN,D.Y.CHIRGADZE,P.J.PARKER, AUTHOR 2 T.L.BLUNDELL,H.R.MOTT REVDAT 4 15-MAY-24 1URF 1 REMARK REVDAT 3 24-FEB-09 1URF 1 VERSN REVDAT 2 11-DEC-03 1URF 1 JRNL REVDAT 1 06-NOV-03 1URF 0 JRNL AUTH D.OWEN,P.N.LOWE,D.NIETLISPACH,C.E.BROSNAN,D.Y.CHIRGADZE, JRNL AUTH 2 P.J.PARKER,T.L.BLUNDELL,H.R.MOTT JRNL TITL MOLECULAR DISSECTION OF THE INTERACTION BETWEEN THE SMALL G JRNL TITL 2 PROTEINS RAC1 AND RHOA AND PROTEIN KINASE C-RELATED KINASE 1 JRNL TITL 3 (PRK1) JRNL REF J.BIOL.CHEM. V. 278 50578 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 14514689 JRNL DOI 10.1074/JBC.M304313200 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN THE REMARK 3 JRNL CITATION ABOVE REMARK 4 REMARK 4 1URF COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-OCT-03. REMARK 100 THE DEPOSITION ID IS D_1290013844. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : 60 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 15N-HSQC; 13C-HSQC; 15N-NOESY; REMARK 210 15N-TOCSY; HNCACB; HCCH-TOCSY; REMARK 210 13C-NOESY; HN(CO)CA; CBCA(CO)NH; REMARK 210 H(CC)(CO)NH REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : AZARA, ANSIG, CNS, ARIA REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 24 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 17 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 FUNCTION: PHOSPHORYLATES RIBOSOMAL PROTEIN S6. MEDIATES REMARK 400 GTPASE RHO DEPENDENT INTRACELLULAR SIGNALLING ENZYME REMARK 400 REGULATION: REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 121 70.04 -69.80 REMARK 500 1 ALA A 122 -134.68 -154.97 REMARK 500 1 SER A 156 -81.30 -49.54 REMARK 500 1 LEU A 193 -52.06 73.33 REMARK 500 1 GLU A 194 106.06 59.43 REMARK 500 1 ASN A 195 -152.23 50.44 REMARK 500 2 ASN A 124 -42.35 73.06 REMARK 500 2 LEU A 125 -42.13 74.57 REMARK 500 2 ASN A 154 -41.66 -136.09 REMARK 500 2 THR A 157 -40.27 -164.42 REMARK 500 2 LYS A 158 -24.87 70.48 REMARK 500 2 GLN A 192 46.16 -78.04 REMARK 500 2 LEU A 193 122.68 -175.82 REMARK 500 2 GLU A 194 -128.23 -76.49 REMARK 500 2 ASN A 195 -50.73 -177.94 REMARK 500 2 ALA A 198 137.64 -174.25 REMARK 500 3 ILE A 120 132.37 -174.16 REMARK 500 3 ASN A 124 140.11 -178.33 REMARK 500 3 THR A 157 133.64 61.66 REMARK 500 3 LYS A 158 42.73 -173.54 REMARK 500 3 GLN A 192 -115.88 -69.08 REMARK 500 3 GLU A 194 35.58 -177.84 REMARK 500 3 ASN A 195 135.28 -178.05 REMARK 500 4 PRO A 121 -135.51 -67.50 REMARK 500 4 ASN A 124 -41.52 179.17 REMARK 500 4 ASN A 154 -164.31 46.52 REMARK 500 4 SER A 156 179.09 62.62 REMARK 500 4 LYS A 158 45.96 -88.49 REMARK 500 4 ALA A 198 56.00 -173.78 REMARK 500 5 PRO A 121 46.26 -80.97 REMARK 500 5 ALA A 122 31.77 -170.73 REMARK 500 5 THR A 123 149.16 55.79 REMARK 500 5 LEU A 125 -42.05 -146.36 REMARK 500 5 ASN A 154 133.73 -176.22 REMARK 500 5 SER A 156 74.64 54.68 REMARK 500 5 THR A 157 140.66 67.79 REMARK 500 5 LYS A 158 50.06 -165.80 REMARK 500 5 GLU A 194 -147.42 -74.02 REMARK 500 5 ASN A 195 127.22 -177.87 REMARK 500 5 ALA A 198 137.11 63.70 REMARK 500 6 PRO A 121 42.98 -79.43 REMARK 500 6 ASN A 124 49.56 -78.52 REMARK 500 6 ASN A 154 -157.74 -65.04 REMARK 500 6 THR A 157 140.17 63.11 REMARK 500 6 LYS A 158 36.53 -166.14 REMARK 500 6 ALA A 198 137.30 -173.07 REMARK 500 7 ILE A 120 133.46 -173.54 REMARK 500 7 THR A 123 -145.73 -74.07 REMARK 500 7 ASN A 124 -44.37 73.81 REMARK 500 7 SER A 153 48.71 -78.41 REMARK 500 REMARK 500 THIS ENTRY HAS 196 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CXZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN RHOA COMPLEXED WITH THE EFFECTORDOMAIN REMARK 900 OF THE PROTEIN KINASE PKN/PRK1 DBREF 1URF A 119 121 PDB 1URF 1URF 119 121 DBREF 1URF A 122 199 UNP Q16512 PKL1_HUMAN 122 199 SEQRES 1 A 81 GLY ILE PRO ALA THR ASN LEU SER ARG VAL ALA GLY LEU SEQRES 2 A 81 GLU LYS GLN LEU ALA ILE GLU LEU LYS VAL LYS GLN GLY SEQRES 3 A 81 ALA GLU ASN MET ILE GLN THR TYR SER ASN GLY SER THR SEQRES 4 A 81 LYS ASP ARG LYS LEU LEU LEU THR ALA GLN GLN MET LEU SEQRES 5 A 81 GLN ASP SER LYS THR LYS ILE ASP ILE ILE ARG MET GLN SEQRES 6 A 81 LEU ARG ARG ALA LEU GLN ALA ASP GLN LEU GLU ASN GLN SEQRES 7 A 81 ALA ALA PRO HELIX 1 1 LEU A 125 GLY A 155 1 31 HELIX 2 2 ASP A 159 LEU A 193 1 35 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1